树突细胞与胶质瘤免疫治疗
出处
《医学综述》
2005年第9期769-771,共3页
Medical Recapitulate
基金
广西壮族自治区区科委回国基金资助(桂科回0342011)
参考文献20
-
1Vandenabeele S, Wu L. Dendritic cell origins: puzzles and paradoxes[J]. Immunol Cell Biol, 1999,77(5) :411-419.
-
2Liu A,Takahashi M,Narita M,et al . Generation of functional and mature dendritic cells from cord blood and bone marrow CD34 < sup > +</sup > cells by two-step culture combined with calcium ionophore treatment[ J]. J Immunol Methods, 2002,261(1/2) :49-63.
-
3Banchereau J, Steinman RM. Dendritic cells and the control of immunity [ J]. Nature, 1998,392(6673 ) : 245-252.
-
4Somasse T, Flamand V, De Becker G, et al. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo[ J]. J Exp Med, 1992,175( 1 ) : 15-21.
-
5Pulendran B, Smith JL, Jenkins M, et al. Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant[J]. J Exp Med, 1998,188( 11 ) :2075-2082.
-
6McCoy KD, Hermans IF, Fraser JH, et al. Cytotoxic T lymphocyte-assodated antigen 4 (CTLA-4) can regulate dendritic cell- induced activation and cytotoxicity of CD8( + ) T cells independently of CD4( + ) T cell help[J] .J Exp Med, 1999,189(7) : 1157-1162.
-
7Mehta-Damani A, Markowicz S, Engleman ES. Generation of antigenspecific CD8+ CTLs from naive precursors[ J]. J Immunol, 1994, 153(3) :996-1003.
-
8Gabrilovich DI, Chen HL, Girgis KR, et al. Production of vascular endothelial 11 growth factor by human tumors inhibits the functional maturation of dendritic cells[J]. Nat Med, 1996,2(10) : 1096-1103.
-
9Steinbrink K, Jonuleit H, Muller G, et al. Interleukin- 10-treated human dendritic cells induce a melanoma-antigen-specificeanergy in CD8( + )T cells resulting in a failure to lyse tumor cells[J]. Blood, 1999,93(5) : 1634-1642.
-
10Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: Intrinsic immunoeffector cell of the brain[J]. Brain Res Rev, 1995,20(3) :269-287.
-
1郑宁,叶胜龙.树突状细胞在抗肿瘤免疫治疗中的应用[J].国外医学（肿瘤学分册）,2001,28(3):180-182. 被引量：1
-
2盛立霞,谢晓宝,邱国强.树突状细胞与肿瘤细胞融合瘤苗研究进展[J].国外医学（肿瘤学分册）,2004,31(5):342-345. 被引量：4
-
3谭广,王忠裕,殷朔,于志红,吕申.IL-23修饰的树突状细胞疫苗抗胰腺癌免疫应答的实验研究[J].中华肝胆外科杂志,2006,12(2):134-136. 被引量：1
-
4张晓文.树突状细胞与膀胱癌的治疗进展[J].国外医学（泌尿系统分册）,2002,22(4):217-219.
-
5黄海,黄健.树突状细胞在前列腺癌治疗中的应用[J].中华国际医学杂志,2003,3(4):345-348.
-
6王星星,蔡绍皙.肿瘤疫苗研究进展[J].肿瘤防治研究,2009,36(12):1072-1074. 被引量：3
-
7刘春燕,张正荣.树突状细胞及其在妇科肿瘤免疫治疗中的研究进展[J].安徽医学,2003,24(6):82-83.
-
8张晓晖,宋善俊.树突状细胞及其在血液恶性肿瘤生物治疗中的作用[J].临床血液学杂志,2002,15(5):235-237.
-
9尹晓玲,孙世良,李少林.白细胞介素联合放射治疗抗肿瘤研究进展[J].四川肿瘤防治,2006,19(1):71-74.
-
10李德春,朱兴国,张勇,傅建新.共刺激分子CD80基因转染对肝癌细胞恶性表型的影响[J].中华实验外科杂志,2004,21(9):1146-1146. 被引量：1
